Cargando…

Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis

BACKGROUND: Klotho (KL) was originally characterized as an aging suppressor gene, and has been identified as a tumor suppressor gene in a variety of cancers, including colorectal cancer. Recent years have witnessed the importance of metabolism transformation in cancer cell malignancies maintenance....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingguo, Li, Yaqi, Liang, Lei, Li, Jing, Luo, Dakui, Liu, Qi, Cai, Sanjun, Li, Xinxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994118/
https://www.ncbi.nlm.nih.gov/pubmed/29884183
http://dx.doi.org/10.1186/s12964-018-0241-2
_version_ 1783330362721566720
author Li, Qingguo
Li, Yaqi
Liang, Lei
Li, Jing
Luo, Dakui
Liu, Qi
Cai, Sanjun
Li, Xinxiang
author_facet Li, Qingguo
Li, Yaqi
Liang, Lei
Li, Jing
Luo, Dakui
Liu, Qi
Cai, Sanjun
Li, Xinxiang
author_sort Li, Qingguo
collection PubMed
description BACKGROUND: Klotho (KL) was originally characterized as an aging suppressor gene, and has been identified as a tumor suppressor gene in a variety of cancers, including colorectal cancer. Recent years have witnessed the importance of metabolism transformation in cancer cell malignancies maintenance. Aberrant cancer cell metabolism is considered to be the hallmark of cancer. Our previous studies demonstrated that KL played negative roles in colon cancer cell proliferation and metastasis. However, its role in the cancer cell reprogramming has seldom been reported. The aim of this study was to examine the role of KL in aerobic glycolysis in colorectal cancer. METHODS: Combining maximum standardized uptake value (SUVmax), which was obtained preoperatively via a PET/CT scan, with immunohistochemistry staining, we analyzed the correlation between SUVmax and KL expression in colorectal cancer tissues. The impact of KL on glucose metabolism and its mechanisms were further validated in vitro and in vivo. RESULTS: Patients with lower KL expression exhibited higher (18)F-FDG uptake (P < 0.05), indicating that KL might participate in aerobic glycolysis regulation. In vitro assay by using colon cancer cell lines further supported this observation. By overexpressing KL in HTC116 and SW480 cells, we observed that the glycolysis was inhibited and the mitochondrial respiration increased, indicating that KL was a negative regulator of aerobic glycolysis. To seek for the underlying mechanisms, we tried to dig out the relation between KL and HIF1α signaling pathway, and found that KL negatively regulated HIF1α protein level and transcriptional activity. Western blot analysis showed that KL overexpression negatively regulated ERK pathway, and KL regulated aerobic glycolysis in part through its regulation of ERK/ HIF1α axis. CONCLUSIONS: Taken together, KL is a negative regulator of aerobic glycolysis and KL inhibited glucose metabolism transformation via the ERK/ HIF1α axis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-018-0241-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5994118
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59941182018-06-21 Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis Li, Qingguo Li, Yaqi Liang, Lei Li, Jing Luo, Dakui Liu, Qi Cai, Sanjun Li, Xinxiang Cell Commun Signal Research BACKGROUND: Klotho (KL) was originally characterized as an aging suppressor gene, and has been identified as a tumor suppressor gene in a variety of cancers, including colorectal cancer. Recent years have witnessed the importance of metabolism transformation in cancer cell malignancies maintenance. Aberrant cancer cell metabolism is considered to be the hallmark of cancer. Our previous studies demonstrated that KL played negative roles in colon cancer cell proliferation and metastasis. However, its role in the cancer cell reprogramming has seldom been reported. The aim of this study was to examine the role of KL in aerobic glycolysis in colorectal cancer. METHODS: Combining maximum standardized uptake value (SUVmax), which was obtained preoperatively via a PET/CT scan, with immunohistochemistry staining, we analyzed the correlation between SUVmax and KL expression in colorectal cancer tissues. The impact of KL on glucose metabolism and its mechanisms were further validated in vitro and in vivo. RESULTS: Patients with lower KL expression exhibited higher (18)F-FDG uptake (P < 0.05), indicating that KL might participate in aerobic glycolysis regulation. In vitro assay by using colon cancer cell lines further supported this observation. By overexpressing KL in HTC116 and SW480 cells, we observed that the glycolysis was inhibited and the mitochondrial respiration increased, indicating that KL was a negative regulator of aerobic glycolysis. To seek for the underlying mechanisms, we tried to dig out the relation between KL and HIF1α signaling pathway, and found that KL negatively regulated HIF1α protein level and transcriptional activity. Western blot analysis showed that KL overexpression negatively regulated ERK pathway, and KL regulated aerobic glycolysis in part through its regulation of ERK/ HIF1α axis. CONCLUSIONS: Taken together, KL is a negative regulator of aerobic glycolysis and KL inhibited glucose metabolism transformation via the ERK/ HIF1α axis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-018-0241-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-08 /pmc/articles/PMC5994118/ /pubmed/29884183 http://dx.doi.org/10.1186/s12964-018-0241-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Qingguo
Li, Yaqi
Liang, Lei
Li, Jing
Luo, Dakui
Liu, Qi
Cai, Sanjun
Li, Xinxiang
Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
title Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
title_full Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
title_fullStr Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
title_full_unstemmed Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
title_short Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
title_sort klotho negatively regulated aerobic glycolysis in colorectal cancer via erk/hif1α axis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994118/
https://www.ncbi.nlm.nih.gov/pubmed/29884183
http://dx.doi.org/10.1186/s12964-018-0241-2
work_keys_str_mv AT liqingguo klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis
AT liyaqi klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis
AT lianglei klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis
AT lijing klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis
AT luodakui klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis
AT liuqi klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis
AT caisanjun klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis
AT lixinxiang klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis